TCRYPTION
TCRyption is a preclinical company focused on the development of novel approaches to TCR based cellular therapy for cancer and other indications. TCRyption seeks to develop a pipeline of product candidates that can treat cancer type and patient populations that are underserved by current approaches.
TCRYPTION
Industry:
Biotechnology Health Care
Founded:
2020-10-01
Address:
New York, New York, United States
Country:
United States
Status:
Active
Total Funding:
10 M USD
Investors List
TIO Bioventures
TIO Bioventures investment in Seed Round - TCRyption